Pericoital UPA + Meloxicam

Product Overview

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Oral

Description: Dosing of ulipristal acetate and meloxicam given at a peak fertility time point. Ulipristal is effective during the follicular time period and the theoretical mechanism of meloxicam to disruption of cumulus-oocyte expansion in a late step of ovulation.

Updated date: December 04, 2017

Vertical Tabs

Status

Project Phase: Early Development

Project Stage: Phase I

Began discovery in: 2017

Status Details:
  • Exploratory prospective study initiated in January 2018 investigating if addition of a COX-2 inhibitor can increase efficacy of ulipristal in disrupting ovulation at peak fertility. Expected study completion in July 2018.

Download Product Report